Plasma fatty acids and lipoproteins in type 2 diabetic patients
2005; Wiley; Volume: 22; Issue: 3 Linguagem: Inglês
10.1002/dmrr.607
ISSN1520-7560
AutoresAnnunziata Lapolla, Giovanni Sartore, Giovanni Roselli della Rovere, Giovanna Romanato, Sabina Zambon, Raffaella Marin, Enzo Manzato, Domenico Fedele,
Tópico(s)Liver Disease Diagnosis and Treatment
ResumoAbstract Background The dyslipidemia of type 2 diabetic patients is characterized by high VLDL, abnormal LDL composition and low HDL cholesterol concentrations. The aim of this study was to establish whether the type of dietary fats affects LDL size and density and HDL cholesterol concentrations in these patients. Methods Plasma phospholipid fatty acid composition, which reflects the type of dietary fatty acids, was quantified by gas chromatography. LDL relative flotation (LDL‐Rf), a measure of LDL particle size and density, was determined by single vertical spin density gradient ultracentrifugation in 97 type 2 diabetic patients. Results By linear regression analysis of the data, plasma fatty acids were associated neither with LDL‐cholesterol levels nor with LDL‐Rf. The HDL cholesterol concentrations were negatively related with saturated fatty acids ( r = −0.23; p = 0.02) but positively related with monounsaturated fatty acids ( r = +0.20; p = 0.00). Furthermore, higher HDL concentrations were associated with large and buoyant LDL particles (HDL cholesterol vs LDL‐Rf: r = +0.47; p = 0.00). In the multiple regression analysis, the LDL‐Rf was significantly related both to triglycerides (β coefficient = −0.55, p = 0.000) and HDL cholesterol (β coefficient = 0.19, p = 0.034) concentrations. In a stepwise regression analysis including both triglycerides and HDL cholesterol, triglycerides alone explained the 43.0% of the LDL‐Rf variability. Conclusions A reduction of the dietary saturated fats and an increment of monounsaturated fats might increase HDL cholesterol concentrations in type 2 diabetic patients. Modifications of LDL composition might be expected from interventions aimed to reduce plasma triglycerides. Copyright © 2005 John Wiley & Sons, Ltd.
Referência(s)